These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16014391)

  • 1. The social realities of adherence to protease inhibitor regimens: substance use, health care and psychological states.
    Halkitis PN; Kutnick AH; Slater S
    J Health Psychol; 2005 Jul; 10(4):545-58. PubMed ID: 16014391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to HIV medications in a cohort of men who have sex with men: impact of September 11th.
    Halkitis PN; Kutnick AH; Rosof E; Slater S; Parsons JT
    J Urban Health; 2003 Mar; 80(1):161-6. PubMed ID: 12612105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of HIV medication adherence in relation to person and treatment characteristics using hierarchical linear modeling.
    Halkitis P; Palamar J; Mukherjee P
    AIDS Patient Care STDS; 2008 Apr; 22(4):323-35. PubMed ID: 18290734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal analysis of HIV treatment adherence among men who have sex with men: a cognitive escape perspective.
    Du Bois SN; McKirnan DJ
    AIDS Care; 2012; 24(11):1425-31. PubMed ID: 22292512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Patient Medication Adherence Questionnaire as a tool for self-reported adherence assessment in HIV-infected patients on antiretroviral regimens.
    Duong M; Piroth L; Grappin M; Forte F; Peytavin G; Buisson M; Chavanet P; Portier H
    HIV Clin Trials; 2001; 2(2):128-35. PubMed ID: 11590521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimens.
    Trotta MP; Ammassari A; Cozzi-Lepri A; Zaccarelli M; Castelli F; Narciso P; Melzi S; De Luca A; Monforte AD; Antinori A; ;
    AIDS; 2003 May; 17(7):1099-102. PubMed ID: 12700467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Social support, substance use, and denial in relationship to antiretroviral treatment adherence among HIV-infected persons.
    Power R; Koopman C; Volk J; Israelski DM; Stone L; Chesney MA; Spiegel D
    AIDS Patient Care STDS; 2003 May; 17(5):245-52. PubMed ID: 12816618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A medication self-management program to improve adherence to HIV therapy regimens.
    Smith SR; Rublein JC; Marcus C; Brock TP; Chesney MA
    Patient Educ Couns; 2003 Jun; 50(2):187-99. PubMed ID: 12781934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adherence to antiretroviral treatments with a protease inhibitor in HIV-infected patients].
    Salmon-Céron D; Deleuze J; Coste J; Guerin C; Ginsburg C; Blanche P; Finkielsztejn L; Pecqueux L; Chaput S; Gorin I; Sicard D
    Ann Med Interne (Paris); 2000 Jun; 151(4):297-302. PubMed ID: 10922958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates.
    Wohl DA; Stephenson BL; Golin CE; Kiziah CN; Rosen D; Ngo B; Liu H; Kaplan AH
    Clin Infect Dis; 2003 Jun; 36(12):1572-6. PubMed ID: 12802758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial of a peer support intervention targeting antiretroviral medication adherence and depressive symptomatology in HIV-positive men and women.
    Simoni JM; Pantalone DW; Plummer MD; Huang B
    Health Psychol; 2007 Jul; 26(4):488-95. PubMed ID: 17605569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of HIV antiretroviral treatments, access and adherence in an ethnically diverse sample of men who have sex with men.
    Halkitis PN; Parsons JT; Wolitski RJ; Remien RH
    AIDS Care; 2003 Feb; 15(1):89-102. PubMed ID: 12655837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of antiretroviral adherence.
    Murphy DA; Marelich WD; Hoffman D; Steers WN
    AIDS Care; 2004 May; 16(4):471-84. PubMed ID: 15203415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives Regarding Adherence to Prescribed Treatment in Highly Adherent HIV-Infected Gay Men.
    Brion JM; Menke EM
    J Assoc Nurses AIDS Care; 2008; 19(3):181-91. PubMed ID: 18457759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social support, coping, and medication adherence among HIV-positive women with depression living in rural areas of the southeastern United States.
    Vyavaharkar M; Moneyham L; Tavakoli A; Phillips KD; Murdaugh C; Jackson K; Meding G
    AIDS Patient Care STDS; 2007 Sep; 21(9):667-80. PubMed ID: 17919094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence, side effects and efficacy of stavudine plus lamivudine plus nelfinavir in treatment-experienced HIV-infected patients.
    Roca B; Gómez CJ; Arnedo A
    J Infect; 2000 Jul; 41(1):50-4. PubMed ID: 10942640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive executive functioning in relation to HIV medication adherence among gay, bisexual, and other men who have sex with men.
    Solomon TM; Halkitis PN
    AIDS Behav; 2008 Jan; 12(1):68-77. PubMed ID: 17636373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to highly active antiretroviral therapy (HAART) medication regimens among HIV-positive men and women.
    Cruess DG; Minor S; Antoni MH; Millon T
    J Pers Assess; 2007 Dec; 89(3):277-90. PubMed ID: 18001228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virological suppression achieved with suboptimal adherence levels among South African children receiving boosted protease inhibitor-based antiretroviral therapy.
    Müller AD; Myer L; Jaspan H
    Clin Infect Dis; 2009 Jan; 48(1):e3-5. PubMed ID: 19025495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The detection of non-adherence by self-administered questionnaires can be optimized by protease inhibitor plasma concentration determination.
    Duran S; Peytavin G; Carrieri P; Raffi F; Ecobichon JL; Pereira E; Cassuto GP; Spire B; Leport C;
    AIDS; 2003 May; 17(7):1096-9. PubMed ID: 12700466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.